Successful management of feline pemphigus foliaceus with pentoxifylline and topical hydrocortisone aceponate

Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

1 Scopus Citations
View graph of relations


Original languageEnglish
Pages (from-to)937-944
Journal / PublicationVeterinary Medicine and Science
Issue number3
Online published25 Feb 2022
Publication statusPublished - May 2022



The treatment regimen for feline pemphigus foliaceus (PF), an autoimmune disease caused by auto-antibodies against proteins of the desmosome junction, usually includes high doses of oral or parenteral immunosuppressive drugs, typically glucocorticoids. This case adds to a growing body of evidence that topical hydrocortisone aceponate is effective for the treatment of feline PF, and demonstrates the practical use of a non-invasive diagnostic method for histopathology when owners refuse a biopsy to support a clinical diagnosis of PF. Finally, this case highlights an international trend of owner-initiated treatment of feline infectious peritonitis (FIP) using unlicensed, unregistered drugs.

Research Area(s)

  • autoimmune disease, dermatology, feline, pemphigus, skin, treatment

Download Statistics

No data available